OAT-4828   Click here for help

GtoPdb Ligand ID: 14643

Synonyms: example 45 [PMID: 42090583] | Example 77 [US12404279] | OAT4828
Compound class: Synthetic organic
Comment: OAT-4828 is a reversible allosteric inhibitor of ubiquitin specific peptidase 7 (USP7) [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 119.74
Molecular weight 571.62
XLogP 0.71
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=C(C(=NC(=C1)C(F)(F)F)C2=C3C(=NC=C2)C=C(CN4C(=O)C5C(C4=O)C5(C)C)S3)C(=O)N6CC[C@@H](C6)NC
Isomeric SMILES CC1(C2C(N(C(C12)=O)CC3=CC4=NC=CC(=C4S3)C5=NC(=CC(=C5C(=O)N6C[C@H](CC6)NC)C)C(F)(F)F)=O)C
InChI InChI=1S/C28H28F3N5O3S/c1-13-9-18(28(29,30)31)34-22(19(13)24(37)35-8-6-14(11-35)32-4)16-5-7-33-17-10-15(40-23(16)17)12-36-25(38)20-21(26(36)39)27(20,2)3/h5,7,9-10,14,20-21,32H,6,8,11-12H2,1-4H3/t14-,20?,21?/m0/s1
InChI Key UMDAQLNUNDVRJT-YJPTXTSQSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Chrzanowski J, Nowicka J, Koralewski R, Joachimiak L, Gzik A, Borek B, Brzezinska J, Kusmirek D, Olejniczak S, Matyszewski K et al.. (2026)
Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.
J Med Chem, 69 (10): 12502-12518. [PMID:42090583]
2. Chrzanowski J, Nowicka J,Joachimiak Ł, Koralewski R, Olejniczak S, Mazur M, Borek B, Gzik A, Matyszewski K, Ciastek-Iskrzycka S et al.. (2025)
Deubiquitinase inhibitors and methods of use thereof.
Patent number: US12404279B2. Assignee: Molecure SA. Priority date: 22/12/2022. Publication date: 02/09/2025.